FDA says Ozempic, Wegovy are not in short supply anymore, which could impact prices
FDA says Ozempic, Wegovy are not in short supply anymore, which could impact prices – CBS News Watch CBS News The U.S. Food and Drug Administration said Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply. CBS News New York reporter Ali Bauman reports on whether
Read More